<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               ADVERSE REACTIONS<BR>               <BR>            Potential adverse reactions to warfarin sodium tablets may include:<BR><BR>                  <BR>                     <BR>                        ●     OVERDOSAGE: Treatment).<BR>              <BR>                  <BR>                  <BR>                     <BR>                        ●     Bleeding which occurs when the PT/INR is within the therapeutic range warrants diagnostic investigation since it may unmask a previously unsuspected lesion, e.g., tumor, ulcer, etc.<BR>              <BR>                  <BR>                  <BR>                     <BR>                        ●     Necrosis of skin and other tissues (seeWARNINGS).<BR>              <BR>                  Adverse reactions reported infrequently include: hypersensitivity/allergic reactions, including anaphylactic reactions, systemic cholesterol microembolization, purple toes syndrome, hepatitis, cholestatic hepatic injury, jaundice, elevated liver enzymes, hypotension, vasculitis, edema, anemia, pallor, fever, rash, dermatitis, including bullous eruptions, urticaria, angina syndrome, chest pain, abdominal pain including cramping, flatulence/bloating, fatigue, lethargy, malaise, asthenia, nausea, vomiting, diarrhea, pain, headache, dizziness, loss of consciousness, syncope, coma, taste perversion, pruritus, alopecia, cold intolerance, and paresthesia including feeling cold and chills.<BR>Rare events of tracheal or tracheobronchial calcification have been reported in association with long-term warfarin therapy. The clinical significance of this event is unknown.<BR>Priapism has been associated with anticoagulant administration, however, a causal relationship has not been established.<BR><BR>                  <BR><BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>